Cargando…

A preliminary study of the effects of cannabidiol (CBD) on brain structure in patients with epilepsy

Cannabis use is associated with changes in brain structure and function; its neurotoxic effects are largely attributed to Δ(9)-tetrahydrocannabidiol. Whether such effects are present in patients with epilepsy exposed to a highly-purified cannabidiol isolate (CBD; Epidiolex®; Greenwich Biosciences, I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Ayushe A., Nenert, Rodolphe, Allendorfer, Jane B., Gaston, Tyler E., Grayson, Leslie P., Hernando, Kathleen, Szaflarski, Jerzy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170322/ https://www.ncbi.nlm.nih.gov/pubmed/32322816 http://dx.doi.org/10.1016/j.ebr.2019.100341

Ejemplares similares

An exploratory study of brain temperature and choline abnormalities in temporal lobe epilepsy patients with depressive symptoms
por: Oates, Mina, et al.
Publicado: (2023)

A Model for Visual Memory Encoding
por: Nenert, Rodolphe, et al.
Publicado: (2014)

A Pilot Randomized Controlled Trial of Intermittent Theta Burst Stimulation as Stand-Alone Treatment for Post-Stroke Aphasia: Effects on Language and Verbal Functional Magnetic Resonance Imaging (fMRI)
por: Allendorfer, Jane B., et al.
Publicado: (2021)

Repeatability and Reproducibility of in-vivo Brain Temperature Measurements
por: Sharma, Ayushe A., et al.
Publicado: (2020)

Corrigendum: Repeatability and Reproducibility of in-vivo Brain Temperature Measurements
por: Sharma, Ayushe A., et al.
Publicado: (2021)

Interhemispheric Plasticity following Intermittent Theta Burst Stimulation in Chronic Poststroke Aphasia
por: Griffis, Joseph C., et al.
Publicado: (2016)

Damage to white matter bottlenecks contributes to language impairments after left hemispheric stroke
por: Griffis, Joseph C., et al.
Publicado: (2017)

Functional Magnetic Resonance Imaging of Language Following Constraint-Induced Aphasia Therapy Primed with Intermittent Theta Burst Stimulation in 13 Patients with Post-Stroke Aphasia
por: Allendorfer, Jane B., et al.
Publicado: (2021)

Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
por: Davis, Brittney H., et al.
Publicado: (2021)

An interaction between warfarin and cannabidiol, a case report
por: Grayson, Leslie, et al.
Publicado: (2017)

FMRI response to acute psychological stress differentiates patients with psychogenic non-epileptic seizures from healthy controls – A biochemical and neuroimaging biomarker study
por: Allendorfer, Jane B., et al.
Publicado: (2019)

White Matter Language Pathways and Language Performance in Healthy Adults Across Ages
por: Houston, James, et al.
Publicado: (2019)

Final analysis of potential drug–drug interactions between highly purified cannabidiol and anti‐seizure medications in an open‐label expanded access program
por: Gaston, Tyler E., et al.
Publicado: (2023)

Sex, Age, and Handedness Modulate the Neural Correlates of Active Learning
por: Nair, Sangeeta, et al.
Publicado: (2019)

Neuroimaging Correlates of Post-Stroke Aphasia Rehabilitation in a Pilot Randomized Trial of Constraint-Induced Aphasia Therapy
por: Nenert, Rodolphe, et al.
Publicado: (2017)

Cannabidiol (CBD) in Cancer Management
por: O’Brien, Kylie
Publicado: (2022)

Seizing the Neuroinflammatory Target: The Quest Continues
por: Sharma, Ayushe A., et al.
Publicado: (2019)

Neuroinflammation as a pathophysiological factor in the development and maintenance of functional seizures: A hypothesis
por: Sharma, Ayushe A., et al.
Publicado: (2021)

White Matter Abnormalities in Patients with Treatment-Resistant Genetic Generalized Epilepsies
por: Szaflarski, Jerzy P., et al.
Publicado: (2016)

Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
por: Gómez, Claudia Taborda, et al.
Publicado: (2021)

Towards Better Delivery of Cannabidiol (CBD)
por: Millar, Sophie Anne, et al.
Publicado: (2020)

Cannabidiol (CBD) and Insomnia : Literature review
por: Gutierrez Higueras, T., et al.
Publicado: (2022)

The use of cannabidiol (CBD) as an analgesic component
por: Petersen, Kristian Kjær-Staal, et al.
Publicado: (2023)

Inhibition of Nicotine Metabolism by Cannabidiol (CBD) and 7-Hydroxycannabidiol (7-OH-CBD)
por: Nasrin, Shamema, et al.
Publicado: (2023)

Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022)

The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
por: Peyravian, Nadia, et al.
Publicado: (2022)

Dispensary Cannabidiol (CBD): Nothing to Worry About!
por: Elliott, Taylor, et al.
Publicado: (2023)

Do people with epilepsy want to participate in an exercise intervention randomized controlled trial? – Results of a brief survey and its preliminary application
por: Mitchell, Brandon S., et al.
Publicado: (2023)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

Induction of neuroplasticity and recovery in post-stroke aphasia by non-invasive brain stimulation
por: Shah, Priyanka P., et al.
Publicado: (2013)

Cannabidiol (CBD) as a Promising Anti-Cancer Drug
por: Seltzer, Emily S., et al.
Publicado: (2020)

Trends in Internet Searches for Cannabidiol (CBD) in the United States
por: Leas, Eric C., et al.
Publicado: (2019)

Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
por: Baswan, Sudhir M, et al.
Publicado: (2020)

Mechanisms of Cannabidiol (CBD) in Cancer Treatment: A Review
por: Heider, Camren G., et al.
Publicado: (2022)

Primary care provider attitudes, experiences and practices about cannabidiol (CBD) and barriers to patient-provider communication about CBD use: A qualitative study
por: Sharma, Pravesh, et al.
Publicado: (2022)

UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations
por: Malaca, Sara, et al.
Publicado: (2021)

The Potential Mechanism of Cannabidiol (CBD) Treatment of Epilepsy in Pentetrazol (PTZ) Kindling Mice Uncovered by Multi-Omics Analysis
por: Lu, Hongyuan, et al.
Publicado: (2023)

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017)

Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies
por: Leas, Eric C., et al.
Publicado: (2020)

Cannabidiol (CBD) modulation of apelin in acute respiratory distress syndrome
por: Salles, Évila Lopes, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nsf7pb5jjhreuh51if655l7d1j